Variable | All cases | Ventriculitis | Colonization only | Controls | P |
---|---|---|---|---|---|
(number = 73) | (number = 6) | (number = 10) | (number = 57) | ||
Age | 61 ± 12.2 | 59.3 ± 14.4 | 65 ± 11.5 | 60.46 ± 12.15 | 0.873 |
Male sex | 37 (50.7) | 2 (33.3) | 5 (50) | 30 (52.6) | 0.667 |
Comorbidities | |||||
Hypertension | 42 (57.5) | 4 (66.7) | 6 (60) | 32 (56.1) | 0.872 |
Diabetes mellitus | 6 (8.2) | 0 (0) | 1 (10) | 5 (8.8) | 0.740 |
Dyslipidemia | 25 (34.2) | 3 (50) | 3 (30) | 19 (33.3) | 0.683 |
Smoking | 15 (20.5) | 2 (33.3) | 0 (0) | 13 (22.8) | 0.186 |
CIC | 9 (12.3) | 0 (0) | 0 (0) | 9 (15.8) | 0.237 |
Previous CVA | 13 (17.8) | 2 (33.3) | 2 (20) | 9 (15.8) | 0.554 |
CRI | 2 (2.7) | 0 (0) | 0 (0) | 2 (3.5) | 0.749 |
Hepatopathy | 2 (2.7) | 0 (0) | 0 (0) | 2 (3.5) | 0.749 |
Neoplasm | 3 (4.1) | 0 (0) | 0 (0) | 3 (5.3) | 0.645 |
Immunodeficiency | 2 (2.7) | 1 (16.7) | 0 (0) | 1 (1.8) | 0.088 |
APACHE II | 20.3 ± 6.8 | 20.5 ± 6.7 | 19.3 ± 8±6 | 20.48 ± 6.58 | 0.675 |
Neurological pathology | 0.051 | ||||
SAH | 31 (42.5) | 3 (50) | 5 (50) | 23 (40.4) | |
ICH | 34 (46.6) | 3 (50) | 2 (20) | 29 (50.9) | |
Primary IVH | 5 (6.8) | 0 (0) | 1 (10) | 4 (7) | |
Acute ischemic stroke | 2 (2.7) | 0 (0) | 2 (20) | 0 (0) | |
Neoplasm | 1 (1.4) | 0 (0) | 0 (0) | 1 (1.8) | |
Secondary IVH | 67 (92) | 6 (100) | 7 (70) | 54 (94.7) | 0.024 |
Type of EVD | 0.022 | ||||
Standard (PVC) | 37 (50.7) | 3 (50) | 6 (60) | 28 (49.1) | |
Antimicrobial impregnated | 31 (42.5) | 2 (33.3) | 3 (30) | 26 (45.6) | |
Silver-impregnated | 1 (1.4) | 1 (16.7) | 0 (0) | 0 (0) | |
Unknown | 4 (5.5) | 0 (0) | 1 (10) | 3 (5.3) | |
Prophylactic antibiotic therapy | 48 (66) | 5 (83) | 9 (90) | 34 (60) | 0.112 |
EVD duration (days) | 9.6 ± 5.3 | 14.8 ± 3.8 | 11.3 ± 4.9 | 8.8 ± 5.12 | 0.019 |
Other nosocomial infections | 0.193 | ||||
Tracheitis | 8 (11) | 1 (16.7) | 1 (10) | 6 (10.5) | |
VAP | 16 (22) | 3 (50) | 5 (50) | 8 (14) | |
CRB | 2 (2.7) | 0 (0) | 0 (0) | 2 (3.5) | |
UTI | 2 (2.7) | 0 (0) | 1 (10) | 1 (1.8) | |
ICU mortality | 27 (37) | 4 (66.7) | 1 (10) | 22 (38.6) | 0.065 |
30-day mortality | 32 (43.8) | 4 (66.7) | 5 (50) | 23 (38.6) | 0.426 |